Contact
Please use this form to send email to PR contact of this press release:
Athenex Announces FDA Allowance of Investigational New Drug Application of Eribulin ORA to Begin Clinical Trials
TO:
Please use this form to send email to PR contact of this press release:
Athenex Announces FDA Allowance of Investigational New Drug Application of Eribulin ORA to Begin Clinical Trials
TO: